United States
Germany
Japan
United Kingdom
China
PLAT (NM_033011) Human Tagged ORF Clone Lentiviral Particle
CAT＃: RC201146L1V
- LentiORF®
-
Lenti ORF particles, PLAT (Myc-DDK tagged) - Human plasminogen activator, tissue (PLAT), transcript variant 3, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 8,930.00
Product images
CNY 1,999.00
CNY 2,700.00
Specifications
| Product Data | |
| Product Name | PLAT (NM_033011) Human Tagged ORF Clone Lentiviral Particle |
| Synonyms | T-PA; TPA |
| Vector | pLenti-C-Myc-DDK |
| ACCN | NM_033011 |
| ORF Size | 1548 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(RC201146).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_033011.1 |
| RefSeq Size | 3035 bp |
| RefSeq ORF | 1551 bp |
| Locus ID | 5327 |
| Domains | KR, Tryp_SPc, EGF |
| Protein Families | Druggable Genome, Protease, Secreted Protein |
| Protein Pathways | Complement and coagulation cascades |
| MW | 57.4 kDa |
| Gene Summary | This gene encodes tissue-type plasminogen activator, a secreted serine protease that converts the proenzyme plasminogen to plasmin, a fibrinolytic enzyme. The encoded preproprotein is proteolytically processed by plasmin or trypsin to generate heavy and light chains. These chains associate via disulfide linkages to form the heterodimeric enzyme. This enzyme plays a role in cell migration and tissue remodeling. Increased enzymatic activity causes hyperfibrinolysis, which manifests as excessive bleeding, while decreased activity leads to hypofibrinolysis, which can result in thrombosis or embolism. Alternative splicing of this gene results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016] |
Documents
| Product Manuals |
| FAQs |
| SDS |
